Ignite Creation Date:
2024-05-06 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 2:24 PM
Study NCT ID:
NCT05226507
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2022-01-13
Brief Title:
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
Sponsor:
Organization:
Nuvectis Pharma Inc